Want to join the conversation?
Effective Jan. 1, 2017, $CVS expects to remove 35 products from its standard formulary, including 10 hyperinflationary products. These formulary changes affect less than 1.5% of plan members, while helping to reduce costs for clients & their members. From 2012-2017, this formulary management will generate savings of more than $9Bil for clients.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.